title: Bevacizumab for retinopathy of prematurity.
authors.forename: Clare E
authors.initials: CE
authors.lastname: Gilbert
authors.forename: Andrea
authors.initials: A
authors.lastname: Zin
authors.forename: Brian
authors.initials: B
authors.lastname: Darlow
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003906:Developing Countries; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D058449:Intravitreal Injections; D053685:Laser Therapy; D012178:Retinopathy of Prematurity / Q000188:drug therapy* / Q000628:therapy; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab